Ah-Leen Rayner
Ah-Leen Rayner is the chief executive of the Breast Cancer Foundation in New Zealand, who has been vocal about the urgent need for funding for the immunotherapy drug Keytruda, particularly for early-stage triple negative breast cancer patients. With a deep understanding of the challenges faced by women diagnosed with this aggressive form of cancer, Rayner advocates for better healthcare policies and access to vital treatments that could save lives.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| New Zealand | 1 | 8.00 | 0.07% | +0% | 4,822,233 | 3,260 | $210,000 | 142$ |
| Totals | 1 | 4,822,233 | 3,260 | $210,000 | 142$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
New Zealand:
Ah-Leen Rayner is the CEO of the Breast Cancer Foundation NZ.
8
New Zealand:
Ah-Leen Rayner is the chief executive of Breast Cancer Foundation NZ.
8
New Zealand:
Ah-Leen Rayner, chief executive of the Breast Cancer Foundation, discusses the need for funding Keytruda for breast cancer treatment.
8